main_id,nct_id,drks_id,ictrp_id,created_at,des_q,des_a,des_c,des_c_error_type,inc_q,inc_a,inc_a_errtype,inc_c,inc_a_error_type,int_q,int_a,int_c,int_a_error_type,pri_q,pri_a,pri_c,pri_a_error_type,sec_q,sec_a,sec_c,sec_a_error_type,bli_q,bli_a,bli_c,bli_a_error_type
3045,NCT02986503,NA,NCT02986503,NCT: 2016-11-25 ICTRP: 2016-11-25 DRKS: NA,1,1,NA,,1,1,NA,NA,,NA,NA,NA,,4,1,Progression not defined,,4,0,Progression not defined; not reported,not reported,NA,NA,NA,
3803,NCT02771535,NA,NCT02771535,NCT: 2016-04-05 ICTRP: 2016-04-05 DRKS: NA,1,1,NA,,1,1,NA,No cutpoint for MINI,,2,1,NA,,4,1,No AM; Follow up after 3 instead of 3.5 years,,5,0,Follow up after 3.5 instead of 3 years. Outcome 7 (remission rate) not reported,not reported,1,1,NA,
15470,NCT00571948,NA,NCT00571948,NCT: 2007-12-11 ICTRP: 2007-12-11 DRKS: NA,1,1,NA,,2,1,NA,NA,,2,0,Meat percentage in intervention 2 not 13% (as registered) but 12%,different dosage,5,1,NA,,4,0,no AM; dietary intake not reported,not reported,1,1,"Quadruple in Register, double in article",
13866,NCT00865501,NA,NCT00865501,NCT: 2009-03-18 ICTRP: 2009-03-18 DRKS: NA,1,0,"Maybe the paper is a byproduct of the registered trial, but it does not follow the registered design, interventions and outcomes.",different design,2,1,NA,NA,,2,0,,different intervention,3,0,"no AM, no metric; not found",not reported,NA,NA,NA,,1,0,"Quadruple in register, but not mentions of blinding in article and since the intervention according to the article was placing the participants in different positions can not possibly be blinded","quadruple in register, no mention in article, impossible to blind"
18712,NCT00069095,NA,NCT00069095,NCT: 2003-09-15 ICTRP: 2003-09-15 DRKS: NA,1,1,NA,,1,1,NA,Criteria more specific in paper,,2,1,NA,,5,1,NA,,4,0,no AM; not reported,not reported,1,1,NA; no info on blinding in article,
18649,NCT00079482,NA,NCT00079482,NCT: 2004-03-08 ICTRP: 2004-03-08 DRKS: NA,1,0,"Paper reports crossover of patients given specific circumstances, but not registered.",different design,2,1,NA,NA,,2,1,NA,,4,1,no measure,,4,1,no measure,,NA,NA,NA,
18029,NCT00171873,NA,NCT00171873,NCT: 2005-09-13 ICTRP: 2005-09-13 DRKS: NA,1,1,NA,,2,1,NA,NA,,2,1,"intervals given, no time frame",,4,1,no measure (definition of progression),,5,0,Follow-up after 6 instead of 3 months,different time frame,1,1,NA,
27202,NCT00168454,DRKS00004022,DRKS00004022,NCT: NA ICTRP: 2012-07-03 DRKS: 2012-07-03,1,1,NA,,1,1,a,NA,,2,1,NA,,5,1,NA,,5,0,Additional scales: KHQ and SF-36. MCC (that is outcome 3) not assessed. Different time frames for number of micturitions.,different time frame,1,1,NA,
18045,NCT00171067,NA,NCT00171067,NCT: 2005-09-10 ICTRP: 2005-09-10 DRKS: NA,1,1,NA,,2,1,NA,NA,,2,1,NA,,4,1,"no AM; Can UACR be regarded the same as ""albumin exretion""?",,3,0,"Registration: no AM, no measure (definition of blood test); Paper: Endpoint 2 of 3 not assessed. Unclear to the rater whether the other endpoints were assessed.",not reported,1,1,NA,
18166,NCT00153530,NA,NCT00153530,NCT: 2005-09-08 ICTRP: 2005-09-08 DRKS: NA,1,1,NA,,2,1,NA,NA,,2,0,"Details on intervention from study description; MTX was given identical to protocol, but additionally ifosfamide, mentioned as protocol amendment in paper.",additional medicine (acknowledged),5,1,NA,,4,1,no measure,,NA,NA,NA,
15095,NCT00654719,NA,NCT00654719,NCT: 2008-04-03 ICTRP: 2008-04-03 DRKS: NA,1,1,NA,,2,0,NA,"Cutpoint for inclusion changed from >= 3 to ""with stable HF New
York Heart Association (NYHA) functional  class II–IV"".",different cutpoint,2,1,NA,,3,1,"no AM, no metric",,3,1,"no AM, no metric",,1,1,NA,
9103,NCT01645150,NA,NCT01645150,NCT: 2012-06-11 ICTRP: 2012-06-11 DRKS: NA,1,1,NA,,1,1,NA,NA,,1,1,NA,,4,0,no AM; Identified as secondary endpoint in paper,outcome switched to secondary,4,1,no AM,,NA,NA,NA,
5466,NCT02397473,NA,NCT02397473,NCT: 2015-03-19 ICTRP: 2015-03-19 DRKS: NA,1,1,NA,,2,0,NA,"Inclusion criteria differ a bit, for example register ""with a history of episodic cluster headache with at least two cluster periods lasting from 7 days to 1 year (when untreated) and separated by pain-free remission periods of >=1 month"" vs. In article ""required to have had a cluster headache period that had lasted at least 6 weeks""",different cutpoint,2,1,NA,,5,1,NA,,5,1,NA,,1,1,NA,
12191,NCT01147185,NA,NCT01147185,NCT: 2010-05-07 ICTRP: 2010-05-07 DRKS: NA,1,1,NA,,2,1,NA,NA,,2,1,NA,,4,0,"no AM; not reported, also 6-month-follow-up not reported (mentioned as limitation in the article)",not reported (acknowledged),5,0,no AM; not reported due to data sparsity (metioned as limitation in paper),not reported (acknowledged),NA,NA,NA,
25359,NCT02021409,DRKS00006416,DRKS00006416,NCT: NA ICTRP: 2014-11-03 DRKS: 2014-11-03,1,1,NA,,2,0,NA,Mean Hb lower value 9 in article instead of 10,different cutpoint,1,1,NA,,4,1,no AM,,5,1,NA,,NA,NA,NA,
8253,NCT01806298,NA,NA,NCT: 2013-03-05 ICTRP: NA DRKS: NA,1,1,NA,,2,0,NA,"BMI cutoff 40 in article, 35 in register",different cutpoint,1,1,NA,,5,1,NA,,5,1,NA,,NA,NA,NA,
35016,NCT02946463,NA,EUCTR2016-002025-11,NCT: NA ICTRP: 2016-10-07 DRKS: NA,1,1,NA,,2,1,NA,NA,,2,0,"extension period for therapy 5 years in register, 2 years in article",different extension period,5,1,NA,,4,1,no AM,,NA,NA,NA,
16730,NCT00388505,NA,NCT00388505,NCT: 2006-10-16 ICTRP: 2006-10-16 DRKS: NA,1,1,NA,,1,1,r,definition of fibrosis; criteria more specific in register,,2,1,NA,,5,1,NA,,5,0,not reported,not reported,NA,NA,NA,
8492,NCT01760083,NA,NCT01760083,NCT: 2013-01-01 ICTRP: 2013-01-01 DRKS: NA,1,1,NA,,2,0,NA,CTO location 12 missing in article,missing criterion,2,1,NA,,4,1,no AM,,4,1,no AM,,NA,NA,NA,
17907,NCT00191516,NA,NCT00191516,NCT: 2005-09-12 ICTRP: 2005-09-12 DRKS: NA,1,1,NA,,1,0,NA,"In register children 6-12, in article 6-17y",different age range,2,1,"info from description; target dose correct, but could be adjusted within a range according to article",,4,1,no AM,,4,0,no AM; PAERS not reported,not reported,NA,NA,NA,
11984,NCT01182428,NA,NCT01182428,NCT: 2010-07-13 ICTRP: 2010-07-13 DRKS: NA,1,1,NA,,2,0,"NA; Typo? Target lesion <28mm in article, but >28mm in register",NA,different cutpoint,1,1,NA,,5,1,NA,,5,1,NA,,1,0,"NA; single-blind (participant) in register, assessor blinded in article and no info on blinding of participants","single-blind (participant) in register, assessor blinded in article and no info on blinding of participants"
14566,NCT00740896,NA,NCT00740896,NCT: 2008-08-22 ICTRP: 2008-08-22 DRKS: NA,1,1,NA,,2,0,NA,age range 20-50 in article instead of >18,different age range,2,1,NA,,3,0,"no AM, time frame seems incorrect",different time frame,4,0,time frame seems incorrect,different time frame,NA,NA,NA,
22868,NA,DRKS00011712,DRKS00011712,NCT: NA ICTRP: 2017-02-06 DRKS: 2017-02-06,1,1,NA,,1,1,NA,NA,,NA,NA,NA,,4,0,"no AM; Minimal differences between cutpoints in published paper and in register: Acromionslope >=25,7°; Acromionindex >=0,73 vs.  acromion slope 25.0° or more, AI 0,75 or more.",different cutpoints,1,1,"no AM, no metric, no time frame, no measure",,NA,NA,NA,
23542,NA,DRKS00009614,DRKS00009614,NCT: NA ICTRP: 2016-06-27 DRKS: 2016-06-27,1,1,NA,,1,1,NA,NA,,2,1,NA,,3,1,Scale and aggregation missing. Details from description,,4,0,Aggregation Method missing; Article: One day difference in follow-up length,different time frame,NA,NA,NA,
26866,NA,DRKS00002426,DRKS00002426,NCT: NA ICTRP: 2012-11-19 DRKS: 2012-11-19,1,1,NA,,1,1,r,NA,,2,1,NA,,4,1,no measure,,4,0,"no measure; best response reported only at end of study, not at all timepoints that are mentioned in register",different time frame,NA,NA,NA,
24160,NA,DRKS00009741,DRKS00009741,NCT: NA ICTRP: 2015-12-04 DRKS: 2015-12-04,1,1,NA,,2,1,NA,NA,,2,0,"NA; Different intervention, but this is the paper linked as ""publication"" in the registry",different intervention,4,0,no AM,,4,1,no AM,,1,1,NA,
28850,NA,NA,ISRCTN97265367,NCT: NA ICTRP: 2008-04-04 DRKS: NA,1,1,NA,,2,1,r,Criteria more specific in register,,2,1,NA,,4,1,Aggregation Method missing,,4,0,Aggregation Method missing; Article: Not reported.,not reported,0,NA,NA,
28918,NA,NA,ISRCTN03693000,NCT: NA ICTRP: 2007-09-27 DRKS: NA,1,0,"Registration mentions ""partial cross-over"" design, but this is not reported or did not take place",different design,2,0,r,"NA; Age 18-65 (with exceptions for older patients) in register, 19-72 in article. ""Participants with mild depressive symptoms on antidepressant treatment can be included if there is a history of moderate or severe symptoms during the current depressive episode"" only mentioned in register",different age range,2,0,NA; maximum dose of Nortriptyline differs,,5,0,NA; First primary outcome not reported,not reported,4,0,no AM; not reported,not reported,0,NA,NA,
29207,NA,NA,ISRCTN55261332,NCT: NA ICTRP: 2005-10-10 DRKS: NA,1,1,NA,,2,1,NA,NA,,1,1,no dosages,,3,0,"no AM, time frame unclear; Primary outcome changed, reasons are given in the article",outcome modified (acknowledged),3,1,"no AM, no time frame",,0,NA,no info,
28190,NA,NA,ISRCTN60475069,NCT: NA ICTRP: 2010-09-15 DRKS: NA,1,1,NA,,1,1,NA,NA,,2,1,NA,,4,1,no measure,,4,0,"no AM; SCORAD was assessed according to article, but not reported",not reported,1,1,NA,